ANI Pharmaceuticals, Inc. (ANIP) is a publicly traded Healthcare sector company. As of May 21, 2026, ANIP trades at $81.97 with a market cap of $1.80B and a P/E ratio of 19.96. ANIP moved +2.07% today. Year to date, ANIP is +4.25%; over the trailing twelve months it is +35.22%. Its 52-week range spans $52.50 to $99.50. Analyst consensus is strong buy with an average price target of $115.20. Rallies surfaces ANIP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
ANIP financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. ANIP recently traded at $81.97. Market cap is $1.80B. P/E ratio is 19.96. Revenue is $923.71M.
| Metric | Value |
|---|---|
| Price | $81.97 |
| Market Cap | $1.80B |
| P/E Ratio | 19.96 |
| EPS | $4.11 |
| Dividend Yield | 0.00% |
| 52-Week High | $99.50 |
| 52-Week Low | $52.50 |
| Volume | 225 |
| Avg Volume | 0 |
| Revenue (TTM) | $923.71M |
| Net Income | $92.15M |
| Gross Margin | 0.00% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $883.37M | $78.34M | $3.50 |
| 2024 | $614.38M | $-18.52M | $-1.04 |
| 2023 | $486.82M | $18.78M | $0.86 |
| 2022 | $316.38M | $-47.90M | $-3.05 |
7 analysts cover ANIP: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $115.20.